User profiles for Adewale Adebajo
 | Adewale Olukayode AdebajoProfessor of Health Services Research Verified email at sheffield.ac.uk Cited by 3694 |
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
…, PJ Mease, JJ Gomez-Reino, AO Adebajo… - Annals of the …, 2014 - ard.bmj.com
Objectives Apremilast, an oral phosphodiesterase 4 inhibitor, regulates inflammatory mediators.
Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared …
Psoriatic Arthritis Long-term Assessment of Clinical Efficacy 1 (PALACE 1) compared …
Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis
…, PJ Mease, JJ Gomez-Reino, AO Adebajo… - The Journal of …, 2015 - jrheum.org
Objective. To evaluate the efficacy and safety of apremilast, an oral phosphodiesterase 4
inhibitor, over 52 weeks in patients with active psoriatic arthritis (PsA) despite prior treatment. …
inhibitor, over 52 weeks in patients with active psoriatic arthritis (PsA) despite prior treatment. …
[HTML][HTML] Can intersectionality help with understanding and tackling health inequalities? Perspectives of professional stakeholders
Background The concept of “intersectionality” is increasingly employed within public health
arenas, particularly in North America, and is often heralded as offering great potential to …
arenas, particularly in North America, and is often heralded as offering great potential to …
Research priorities to improve stroke outcomes
The James Lind Alliance (JLA) Stroke Priority Setting Partnership involved stroke survivors,
carers, and healthcare and other professionals in setting the research agenda by identifying …
carers, and healthcare and other professionals in setting the research agenda by identifying …
Rheumatic diseases in African blacks
A Adebajo, P Davis - Seminars in arthritis and rheumatism, 1994 - Elsevier
Contrary to previous belief, there is increasing evidence that a broad spectrum of rheumatic
diseases do affect African blacks. Although properly conducted epidemiological studies …
diseases do affect African blacks. Although properly conducted epidemiological studies …
The impact of COVID-19 on rheumatology practice across Africa
Objectives To identify the changes in rheumatology service delivery across the five regions
of Africa from the impact of the COVID-19 pandemic. Methods The COVID-19 African …
of Africa from the impact of the COVID-19 pandemic. Methods The COVID-19 African …
Apremilast: a PDE4 inhibitor for the treatment of psoriatic arthritis
H Abdulrahim, S Thistleton, AO Adebajo… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: The evidence base for disease-modifying anti-rheumatic drugs used in psoriatic
arthritis (PsA) is surprisingly weak, with most having little robust evidence to support their …
arthritis (PsA) is surprisingly weak, with most having little robust evidence to support their …
“I suddenly felt I'd aged”: a qualitative study of patient experiences of polymyalgia rheumatica (PMR)
Objectives To explore patient experiences of living with, and receiving treatment for, PMR.
Methods Semi-structured qualitative interviews, with 22 patients with PMR recruited from …
Methods Semi-structured qualitative interviews, with 22 patients with PMR recruited from …
Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working …
…, SM Cembalo, E Spitz, CL Adams, A Adebajo… - Seminars in Arthritis and …, 2021 - Elsevier
Objective Towards developing an instrument to measure knee and hip osteoarthritis (KHOA)
flare, the Outcome Measures in Rheumatology (OMERACT) Flares in OA Working Group …
flare, the Outcome Measures in Rheumatology (OMERACT) Flares in OA Working Group …
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: results from a multi-stepped consensus-building …
Objective To gain consensus on the Outcome Measures in Rheumatology (OMERACT) core
domain set for rheumatology trials of shared decision making (SDM) interventions. Methods …
domain set for rheumatology trials of shared decision making (SDM) interventions. Methods …
